The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Tumor-Conditioned Macrophages Secrete Migration-Stimulating Factor: A New Marker for M2-Polarization, Influencing Tumor Cell Motility
Open accessAbstract
Tumor-associated macrophages (TAMs) are key orchestrators of the tumor microenvironment directly affecting neoplastic cell growth, neoangiogenesis, and extracellular matrix remodeling. In turn, the tumor milieu strongly influences maturation of TAMs and shapes several of their features. To address the early macrophage (Mϕ) differentiation phase in a malignant context, we mimicked a tumor microenvironment by in vitro coculturing human blood monocytes with conditioned media from different cancer cell lines. Only 2 out of 16 tumor cell lines induced Mϕ differentiation due to secreted M-CSF isoforms, including high molecular mass species. A global gene profiling of tumor-conditioned Mϕ was performed. Comparison with other datasets (polarized M1-Mϕ, M2-Mϕ, and TAMs isolated from human tumors) highlighted the upregulation of several genes also shared by TAM and M2-polarized Mϕ. The most expressed genes were selenoprotein 1, osteoactivin, osteopontin, and, interestingly, migration-stimulating factor (MSF), a poorly studied oncofoetal isoform of fibronectin. MSF (present in fetal/cancer epithelial and stromal cells but not in healthy tissues) was never identified in Mϕ. MSF production was confirmed by immunohistochemistry in human TAMs. MSF was induced by M-CSF, IL-4, and TGFβ but not by proinflammatory stimuli. RNA and protein analysis clearly demonstrated that it is specifically associated with the M2 polarization of Mϕ. Tumor-conditioned Mϕ-derived MSFs strongly stimulated tumor cell migration, thus contributing to the motile phenotype of neoplastic cells. In conclusion, MSF is a new molecule associated with the M2 polarization of Mϕ and expressed by TAMs. Its biological function may contribute to Mϕ-mediated promotion of cancer cell invasion and metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Deepak, P., Kumar, S., & Acharya, A. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03427.x · Cited by 21
RetractedMantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Self-citationGoodall, C. (1988) · Technometrics · doi:10.1080/00401706.1988.10488412 · Cited by 8,675
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Chiang, L. H., Russell, E. L., & Braatz, R. D. (2001) · Advanced Textbooks in Control and Signal Processing · doi:10.1007/978-1-4471-0347-9_4 · Cited by 6,594
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Self-citationMonocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125
Self-citationMacrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Identifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
Self-citationTumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
Self-citationDave, S. S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R. D., Chan, W. C., Fisher, R. I., Braziel, R. M., Rimsza, L. M., Grogan, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041869 · Cited by 1,418
DeNardo, D. G., Barreto, J. B., Andreu, P., Vasquez, L., Tawfik, D., Kolhatkar, N., & Coussens, L. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.018 · Cited by 1,353
Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Steidl, C., Lee, T., Shah, S. P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S. J., Iqbal, J., Weisenburger, D. D., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905680 · Cited by 1,262
Macrophage Polarization Comes of Age
Mantovani, Sica, & Locati, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.001 · Cited by 1,259
Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.11.012 · Cited by 1,231
Denhardt, D. T., Noda, M., O’Regan, A. W., Pavlin, D., & Berman, J. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12980 · Cited by 1,059
Hiratsuka, S., Watanabe, A., Aburatani, H., & Maru, Y. (2006) · Nature Cell Biology · doi:10.1038/ncb1507 · Cited by 1,015
TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4
Padua, D., Zhang, X. H.-F., Wang, Q., Nadal, C., Gerald, W. L., Gomis, R. R., & Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.01.046 · Cited by 952
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)
Weber, G. F., Ashkar, S., Glimcher, M. J., & Cantor, H. (1996) · Science · doi:10.1126/science.271.5248.509 · Cited by 949
Role of tumor-associated macrophages in tumor progression and invasion
Mantovani, A., Schioppa, T., Porta, C., Allavena, P., & Sica, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9001-7 · Cited by 888
Self-citationCSF-1 regulation of the wandering macrophage: complexity in action
Pixley, F. J., & Stanley, E. R. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.09.016 · Cited by 807
Raychaudhuri, S., Stuart, J. M., & Altman, R. B. (1999) · Biocomputing 2000 · doi:10.1142/9789814447331_0043 · Cited by 762
Osteopontin: role in cell signaling and cancer progression
Rangaswami, H., Bulbule, A., & Kundu, G. C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.12.005 · Cited by 735
Biswas, S. K. (2006) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 696
Goerdt, S., & Orfanos, C. E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80014-x · Cited by 682
Preparing the “Soil”: The Premetastatic Niche
Kaplan, R. N., Rafii, S., & Lyden, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2407 · Cited by 665
Qian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., & Pollard, J. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006562 · Cited by 664
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Lazennec, G., & Richmond, A. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.003 · Cited by 650
Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease
Scatena, M., Liaw, L., & Giachelli, C. M. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.144824 · Cited by 644
Porta, C., Rimoldi, M., Raes, G., Brys, L., Ghezzi, P., Di Liberto, D., Dieli, F., Ghisletti, S., Natoli, G., De Baetselier, P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809784106 · Cited by 627
Self-citationRoca, H., Varsos, Z. S., Sud, S., Craig, M. J., Ying, C., & Pienta, K. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042671 · Cited by 569
Protection against reactive oxygen species by selenoproteins
Steinbrenner, H., & Sies, H. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.02.014 · Cited by 520
Liaw, L., Skinner, M. P., Raines, E. W., Ross, R., Cheresh, D. A., Schwartz, S. M., & Giachelli, C. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117718 · Cited by 512
Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.
Ffrench-Constant, C., Van de Water, L., Dvorak, H. F., & Hynes, R. O. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.2.903 · Cited by 486
Saccani, A., Schioppa, T., Porta, C., Biswas, S. K., Nebuloni, M., Vago, L., Bottazzi, B., Colombo, M. P., Mantovani, A., & Sica, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1867 · Cited by 455
Self-citationMacrophages define the invasive microenvironment in breast cancer
Pollard, J. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107762 · Cited by 417
Hagemann, T. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh146 · Cited by 375
Immune cells as mediators of solid tumor metastasis
DeNardo, D. G., Johansson, M., & Coussens, L. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9100-0 · Cited by 372
Van Ginderachter, J. A., Movahedi, K., Hassanzadeh Ghassabeh, G., Meerschaut, S., Beschin, A., Raes, G., & De Baetselier, P. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.06.002 · Cited by 371
Tsutsui, S., Yasuda, K., Suzuki, K., Tahara, K., Higashi, H., & Era, S. (2005) · Oncology Reports · doi:10.3892/or.14.2.425 · Cited by 366
Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells
Shinohara, M. L., Lu, L., Bu, J., Werneck, M. B. F., Kobayashi, K. S., Glimcher, L. H., & Cantor, H. (2006) · Nature Immunology · doi:10.1038/ni1327 · Cited by 360
Zardi, L., Carnemolla, B., Siri, A., Petersen, T. E., Paolella, G., Sebastio, G., & Baralle, F. E. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02509.x · Cited by 338
Osteopontin expression and distribution in human carcinomas.
Brown, L. F., Papadopoulos-Sergiou, A., Berse, B., Manseau, E. J., Tognazzi, K., Perruzzi, C. A., Dvorak, H. F., & Senger, D. R. (1994) · PubMed Central · Cited by 329
Hur, E. M., Youssef, S., Haws, M. E., Zhang, S. Y., Sobel, R. A., & Steinman, L. (2007) · Nature Immunology · doi:10.1038/ni1415 · Cited by 318
The fibronectin isoform containing the ed‐b oncofetal domain: A marker of angiogenesis
Castellani, P., Viale, G., Dorcaratto, A., Nicolo, G., Kaczmarek, J., Querze, G., & Zardi, L. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590507 · Cited by 316
Inflammatory cell infiltration of tumors: Jekyll or Hyde
Talmadge, J. E., Donkor, M., & Scholar, E. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9072-0 · Cited by 313
Vargas-Roig, L. M., Gago, F. E., Tello, O. M., Aznar, J. C., & Ciocca, D. R. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981023)79:5<502::aid-ijc10>3.0.co;2-3 · Cited by 302
Multiple sites of alternative splicing of the rat fibronectin gene transcript.
Schwarzbauer, J. E., Patel, R. S., Fonda, D., & Hynes, R. O. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02547.x · Cited by 299
Singhal, H., Bautista, D., Tonkin, K. S., O’Malley, F. P., Tuck, A. B., Chambers, A. F., & Harris, J. F. (1997) · PubMed · Cited by 285
Kazanecki, C. C., Uzwiak, D. J., & Denhardt, D. T. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21558 · Cited by 275
Fibronectins in vascular morphogenesis
Astrof, S., & Hynes, R. O. (2009) · Angiogenesis · doi:10.1007/s10456-009-9136-6 · Cited by 271
nmb, a novel gene, is expressed in low‐metastatic human melanoma cell lines and xenografts
Weterman, M. A. J., Ajubi, N., van Dinter, I. M. R., Degen, W. G. J., van Muijen, G. N. P., Ruiter, D. J., & Bloemers, H. P. J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600111 · Cited by 256
Bellahcène, A., & CASTRONOVO, V. (1995) · Europe PMC (PubMed Central) · Cited by 240
Ojalvo, L. S., Whittaker, C. A., Condeelis, J. S., & Pollard, J. W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902360 · Cited by 238
Kzhyshkowska, J., Mamidi, S., Gratchev, A., Kremmer, E., Schmuttermaier, C., Krusell, L., Haus, G., Utikal, J., Schledzewski, K., Scholtze, J., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2843 · Cited by 212
The fibronectin gene as a model for splicing and transcription studies
Kornblihtt, A. R., Pesce, C. G., Alonso, C. R., Cramer, P., Srebrow, A., Werbajh, S., & Muro, A. F. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.2.8641558 · Cited by 204
Osteopontin as a Mediator of NKT Cell Function in T Cell-Mediated Liver Diseases
Diao, H., Kon, S., Iwabuchi, K., Kimura, C., Morimoto, J., Ito, D., Segawa, T., Maeda, M., Hamuro, J., Nakayama, T., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.012 · Cited by 195
Senger, D. R., Perruzzi, C. A., Gracey, C. F., Papadopoulos, A., & Tenen, D. G. (1988) · PubMed · Cited by 187
Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma
Nevala, W. K., Vachon, C. M., Leontovich, A. A., Scott, C. G., Thompson, M. A., Markovic, S. N., & for the Melanoma Study Group of the Mayo Clinic Cancer Center (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1980 · Cited by 178
Hassanzadeh Ghassabeh, G., De Baetselier, P., Brys, L., Noël, W., Van Ginderachter, J. A., Meerschaut, S., Beschin, A., Brombacher, F., & Raes, G. (2006) · Blood · doi:10.1182/blood-2005-04-1485 · Cited by 177
Shikano, S., Bonkobara, M., Zukas, P. K., & Ariizumi, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008539200 · Cited by 167
Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks
O'Regan, A. W., Nau, G. J., Chupp, G. L., & Berman, J. S. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01715-1 · Cited by 165
Kaczmarek, J., Castellani, P., Nicolo, G., Spina, B., Allemanni, G., & Zardi, L. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590104 · Cited by 159
T-bet-dependent expression of osteopontin contributes to T cell polarization
Shinohara, M. L., Jansson, M., Hwang, E. S., Werneck, M. B. F., Glimcher, L. H., & Cantor, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508666102 · Cited by 153
Osteopontin: a bridge between bone and blood
Haylock, D. N., & Nilsson, S. K. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06218.x · Cited by 150
Overexpression of osteopontin in hepatocellular carcinoma
Gotoh, M., Sakamoto, M., Kanetaka, K., Chuuma, M., & Hirohashi, S. (2002) · Pathology International · doi:10.1046/j.1440-1827.2002.01316.x · Cited by 148
Schor, S. L., & Schor, A. M. (2001) · Breast Cancer Research · doi:10.1186/bcr325 · Cited by 148
Rich, J. N., Shi, Q., Hjelmeland, M. D., Cummings, T. J., Kuan, C., Bigner, D. D., Counter, C. M., & Wang, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211498200 · Cited by 148
Mundy, G. R. (2008) · Bone · doi:10.1016/j.bone.2007.12.198 · Cited by 147
Schor, S. L., Schor, A. M., Grey, A. M., & Rushton, G. (1988) · Journal of Cell Science · doi:10.1242/jcs.90.3.391 · Cited by 144
Kuroda, E., Ho, V. W., Rüschmann, J., Antignano, F., Hamilton, M. J., Rauh, M. J., Antov, A., Flavell, R. A., Sly, L. M., & Krystal, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900864 · Cited by 134
Perrier, P., Martínez, F., Locati, M., Bianchi, G., Nebuloni, M., Vago, G., Bazzoni, F., Sozzani, S., Allavena, P., & Mantovani, A. (2003) · Journal of Immunology · doi:10.4049/jimmunol.172.11.7031 · Cited by 130
Self-citationIdentification of a third region of cell-specific alternative splicing in human fibronectin mRNA.
Gutman, A., & Kornblihtt, A. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7179 · Cited by 128
Schor, S. L., Schor, A. M., Rushton, G., & Smith, L. (1985) · Journal of Cell Science · doi:10.1242/jcs.73.1.221 · Cited by 113
Ginderachter, J. A. V., Meerschaut, S., Liu, Y., Brys, L., Groeve, K. D., Ghassabeh, G. H., Raes, G., & BAETSELIER, P. D. (2006) · Blood · doi:10.1182/blood-2005-09-3777 · Cited by 109
Labat‐Robert, J. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00022-6 · Cited by 105
Identifying Potential Tumor Markers and Antigens by Database Mining and Rapid Expression ScreeningPreprint
Loging, W., Lal, A., Siu, I., Loney, T. L., Wikstrand, C. J., Marra, M. A., Prange, C. K., Bigner, D. D., Strausberg, R. L., & Riggins, G. J. (2000) · Genome Research · doi:10.1101/gr.138000 · Cited by 103
Ogawa, T., Nikawa, T., Furochi, H., Kosyoji, M., Hirasaka, K., Suzue, N., Sairyo, K., Nakano, S., Yamaoka, T., Itakura, M., et al. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00565.2004 · Cited by 96
Bosschaerts, T., Guilliams, M., Noël, W., Hérin, M., Burk, R. F., Hill, K. E., Brys, L., Raes, G., Ghassabeh, G. H., BAETSELIER, P. D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6168 · Cited by 95
Onaga, M., Ido, A., Hasuike, S., Uto, H., Moriuchi, A., Nagata, K., Hori, T., Hayash, K., & Tsubouchi, H. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00361-1 · Cited by 89
Deregulation of Alternative Splicing of Fibronectin Pre-mRNA in Malignant Human Liver Tumors
Oyama, F., Hirohashi, S., Shimosato, Y., Titani, K., & Sekiguchi, K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81621-0 · Cited by 88
Ellis, I., Grey, A. M., Schor, A. M., & Schor, S. L. (1992) · Journal of Cell Science · doi:10.1242/jcs.102.3.447 · Cited by 86
Schor, S. L., Schor, A. M., Grey, A. M., Chen, J., Rushton, G., Grant, M. E., & Ellis, I. (1989) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02623727 · Cited by 85
Schor, S. L., Ellis, I., Jones, S. J., Baillie, R., Seneviratne, K., Clausen, J., Motegi, K., Vojtesek, B., Kaňková, K., Furrie, E., et al. (2003) · PubMed · Cited by 76
Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy
Cheadle, E. J., Riyad, K., Subar, D. A., Rothwell, D. G., Ashton, G., Batha, H., Sherlock, D., Hawkins, R. E., & Gilham, D. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1145 · Cited by 65
Midulla, M., Verma, R., Pignatelli, M. N., Ritter, M. A., Courtenay-Luck, N. S., & George, A. J. T. (2000) · PubMed · Cited by 64
Science, C. M. (1990) · Lung Cancer · doi:10.1016/0169-5002(90)90156-g · Cited by 64
An, T., Sood, U., Pietruk, T., Cummings, G., Hashimoto, K., & Crissman, J. D. (1987) · PubMed Central · Cited by 59
Macrophages, PPARs, and Cancer
Ginderachter, J. A. V., Movahedi, K., den Bossche, J. V., & BAETSELIER, P. D. (2008) · PPAR Research · doi:10.1155/2008/169414 · Cited by 55
Upregulation of Monocyte/Macrophage HGFIN (Gpnmb/Osteoactivin) Expression in End-Stage Renal Disease
Pahl, M. V., Vaziri, N. D., Yuan, J. J., & Adler, S. G. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03390509 · Cited by 54
Furochi, H., Tamura, S., Takeshima, K., Hirasaka, K., Nakao, R., Kishi, K., & Nikawa, T. (2007) · The Journal of Medical Investigation · doi:10.2152/jmi.54.248 · Cited by 44
Balza, E., Sassi, F., Ventura, E., Parodi, A., Fossati, S., Blalock, W. L., Carnemolla, B., Castellani, P., Zardi, L., & Borsi, L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24473 · Cited by 33
Cited by
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Self-citationCSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Macrophage plasticity and polarization in tissue repair and remodelling
Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., & Locati, M. (2013) · The Journal of Pathology · doi:10.1002/path.4133 · Cited by 2,384
Self-citationTumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“By producing migration-stimulating factors, TAMs give tumor cells the ability of motility and metastasis [93].”
BackgroundUnderstanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Rőszer, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/816460 · Cited by 1,762
Metadata
- Authors
- Solinas, G., Schiarea, S., Liguori, M., Fabbri, M., Pesce, S., Zammataro, L., Pasqualini, F., Nebuloni, M., Chiabrando, C., Mantovani, A., & Allavena, P.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-01
- Volume
- 185
- Issue
- 1
- Pages
- 642-652
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2151399255
- Cited by
- 370
- References
- 105
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.